The Swiss heart surgeon Paul R. Vogt from the University Hospital Zurich has called for large studies on drug therapies for the early treatment of Covid-19. He explained that such interventions from general practitioners could prevent hospitalization and enable healing.
Vogt pointed out that data from many smaller studies showed that 80 to 90 percent of Covid hospitalizations could be prevented. He said he had tried the drug therapy on himself when he fell ill with Covid-19 and after three days he was fit again.
Vogt said he suspected that such therapies were neglected in favor of mass vaccination, through which the pharmaceutical industry could achieve high profits. Vogt, together with the Zurich lawyer Mathias Erne, has urged health authorities and parliamentarians to fund drug therapies, but have received no response.
According to Erne, the common good must come first. It cannot be that the population serves the pharmaceutical industry.
The lipid nanoparticles in mRNA vaccines lead to “rapid and robust inflammatory symptoms” with increased mortality in mice, a study from the Thomas Jefferson University of Philadelphia has revealed.
Lipid nanoparticles used in preclinical studies with nucleoside-modified mRNA vaccines, “are highly inflammatory in mice. Intradermal and intramuscular injection of these LNPs resulted in rapid and robust inflammatory responses characterized by massive neutrophil infiltration, activation of various inflammatory pathways, and production of various inflammatory cytokines and chemokines”.
The same dose of LNP given “intranasally produced similar inflammatory responses in the lungs and resulted in a high mortality rate, although the mechanism is not yet understood. The effectiveness of the mRNA-LNP platforms in inducing adaptive immune responses and the observed side effects could thus be due to the highly inflammatory nature of the LNP,” the authors concluded.